These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

80 related articles for article (PubMed ID: 3605254)

  • 1. Beneficial effects of U-63,557A, a thromboxane synthetase inhibitor, in an ovine model of pregnancy-induced hypertension.
    Keith JC; Thatcher CD; Schaub RG
    Am J Obstet Gynecol; 1987 Jul; 157(1):199-203. PubMed ID: 3605254
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Reduced myocardial neutrophil accumulation and infarct size following thromboxane synthetase inhibitor or receptor antagonist.
    Nichols WW; Mehta J; Wargovich TJ; Franzini D; Lawson D
    Angiology; 1989 Mar; 40(3):209-21. PubMed ID: 2537051
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ridogrel improves maternal/fetal homeostasis in an ovine model of pregnancy-induced hypertension.
    Keith JC; Endo Y; Warwick K; Keith KE; Brugh S; Rowles TK
    Prostaglandins; 1994 Mar; 47(3):247-63. PubMed ID: 8016393
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of thromboxane synthetase inhibition on platelet function and morphology during ovine pregnancy-induced hypertension.
    Miller KW; Keith JC
    Thromb Haemost; 1988 Dec; 60(3):365-71. PubMed ID: 3238644
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Beneficial effect of a thromboxane synthetase inhibitor in traumatic shock.
    Hock CE; Lefer AM
    Circ Shock; 1984; 14(3):159-68. PubMed ID: 6542462
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Thromboxane synthetase inhibition produces maternal and fetal vasodilation during ovine pregnancy-induced hypertension: a Doppler flow velocimetric study.
    Keith JC; Moskal T; Eggleston MK; Konczal C; Howerton TL
    J Perinatol; 1992 Sep; 12(3):210-4. PubMed ID: 1432274
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Erythrocyte morphologic features and serum chemistry studies in ovine pregnancy-induced hypertension treated with thromboxane synthetase inhibitors.
    Miller KW; Keith JC
    Am J Obstet Gynecol; 1988 Nov; 159(5):1241-6. PubMed ID: 3189458
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of cyclooxygenase and thromboxane synthetase inhibition on furosemide-stimulated plasma renin activity.
    Datar S; McCauley FA; Wilson TW
    Can J Physiol Pharmacol; 1987 Jan; 65(1):80-3. PubMed ID: 3105853
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Testing the "redirection hypothesis" of prostaglandin metabolism in the kidney.
    Datar S; McCauley FA; Wilson TW
    Prostaglandins; 1987 Feb; 33(2):275-85. PubMed ID: 3296006
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of thromboxane synthetase inhibition on maternal-fetal homeostasis in gravid ewes with ovine pregnancy-induced hypertension.
    Keith JC; Miller K; Eggleston MK; Kutruff J; Howerton T; Konczal C; McDaniels C
    Am J Obstet Gynecol; 1989 Nov; 161(5):1305-13. PubMed ID: 2589456
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Reduction in myocardial neutrophil accumulation and infarct size following administration of thromboxane inhibitor U-63,557A.
    Wargovich TJ; Mehta J; Nichols WW; Ward MB; Lawson D; Franzini D; Conti CR
    Am Heart J; 1987 Nov; 114(5):1078-85. PubMed ID: 2960223
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of low-dose aspirin on fetal and maternal generation of thromboxane by platelets in women at risk for pregnancy-induced hypertension.
    Benigni A; Gregorini G; Frusca T; Chiabrando C; Ballerini S; Valcamonico A; Orisio S; Piccinelli A; Pinciroli V; Fanelli R
    N Engl J Med; 1989 Aug; 321(6):357-62. PubMed ID: 2664523
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Fetal and maternal response to intravenous infusion of a thromboxane synthetase inhibitor.
    Cardin JP; Ross MG; Ervin MG; Schaffer AV; Douglas FL; Simke JP
    Am J Obstet Gynecol; 1990 Oct; 163(4 Pt 1):1345-9. PubMed ID: 2220946
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A high plasma prostaglandin to thromboxane ratio protects against renal ischemia.
    Kaufman RP; Anner H; Kobzik L; Valeri CR; Shepro D; Hechtman HB
    Surg Gynecol Obstet; 1987 Nov; 165(5):404-9. PubMed ID: 3672299
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacological, hematological, and physiological effects of a new thromboxane synthetase inhibitor (CGS-13080) during cardiopulmonary bypass in dogs.
    DeCampli WM; Goodwin D; Kosek JC; Handen CE; Mitchell RS; Miller DC
    Ann Thorac Surg; 1986 Dec; 42(6):690-6. PubMed ID: 3789860
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Use of a thromboxane synthetase inhibitor, dazoxiben, during haemodialysis.
    Dodd NJ; Gordge MP; Weston MJ
    Br J Clin Pharmacol; 1983; 15 Suppl 1(Suppl 1):67S-70S. PubMed ID: 6337605
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Interferon-alpha elevates pulmonary blood pressure in sheep--the role of thromboxane cascade.
    Hanaoka M; Kubo K; Hayano T; Koizumi T; Kobayashi T
    Eur J Pharmacol; 1999 Apr; 370(2):145-51. PubMed ID: 10323263
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of OKY-046, a selective thromboxane synthetase inhibitor, on endotoxin-induced lung injury in unanesthetized sheep.
    Kubo K; Kobayashi T
    Am Rev Respir Dis; 1985 Sep; 132(3):494-9. PubMed ID: 3898941
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Vasoactive mediators in pregnancy-induced hypertensive disorders: a longitudinal study.
    Paarlberg KM; de Jong CL; van Geijn HP; van Kamp GJ; Heinen AG; Dekker GA
    Am J Obstet Gynecol; 1998 Dec; 179(6 Pt 1):1559-64. PubMed ID: 9855596
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of thromboxane synthase inhibition on air emboli lung injury in sheep.
    Fukushima M; Kobayashi T
    J Appl Physiol (1985); 1986 Jun; 60(6):1828-33. PubMed ID: 3755131
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.